AARDEX Group

Company News

Adherence in Decentralized Clinical Trials

Addressing Medication Adherence in Decentralized Clinical Trials

Adherence monitoring can minimize variability and maximize engagement in DCTs Decentralized clinical trials (DCT) are growing in popularity, thanks to their ability to tear down many of the long-standing barriers to robust medical research. And while this new model has … Read More

AARDEX and Schreiner MediPharm reinforce their collaboration to Enhance Medication Adherence Management

AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence … Read More

AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence

AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence … Read More

A Digital Innovation for the Personalized Management of Adherence

Bernard Vrijens our CEO and Scientific Lead, and Anna-Elisa Hein realizing a master thesis placement at AARDEX Group, conducted a study analyzing the strengths, weaknesses, threats, and opportunities of digital innovation for the personalized management of medication adherence. Anna-Elisa interviewed … Read More

ONdrugDelivery October Issue is now live which includes a contribution of AARDEX Group

AARDEX’s Scientific Lead Bernard Vrijens and Biocorp’s business development director Arnaud Guillet give some details about their companies alliance. They explain how Biocorp’s Injay connected prefilled syringe (PFS) combined with AARDEX’s MEMS Adherence Software provides a mean to tackle the … Read More

The Contract Pharma October Issue is now live which includes an article about AARDEX Group

Medication adherence, which involves patients taking medications in accordance with how they have been prescribed, is a widespread challenge, with wide-reaching implications for patients and health services worldwide. Managing patient compliance can make the difference between failed and successful clinical … Read More

AARDEX announces the world’s first DIGITAL MEDICATION ADHERENCE MONITORING solution fully integrated in the clinical trial platform by a top 10 pharma company.

AARDEX is proud to announce the integration of its MEMS® Adherence Software by a major pharmaceutical company. It’s the first end-to-end integration of electronically compiled dosing histories using smart packages from interactive response technology (IRT) into electronical data capture systems … Read More

How digital medication adherence monitoring increases the impact of innovative adherence research?

MEMS® has been a part of successful adherence research for more than 30 years.Download this adherence compendium and find out how digital medication adherence monitoring increases the impact of academic research findings.

Aardex Pharma Video

This video shows how to speed up your drug development.

Discover why the Pharmaceutical world trusts us to resolve patient non-compliance. … Read More

blog-image

AARDEX leading position in the B2B medication adherence market

AARDEX still confirms its leading position in the B2B medication adherence market … Read More